These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7981771

  • 21. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY, Hydock DS, Schneider CM, Hayward R.
    Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
    [Abstract] [Full Text] [Related]

  • 22. Vitamin A inhibits doxorubicin-induced membrane lipid peroxidation in rat tissues in vivo.
    Ciaccio M, Valenza M, Tesoriere L, Bongiorno A, Albiero R, Livrea MA.
    Arch Biochem Biophys; 1993 Apr; 302(1):103-8. PubMed ID: 8470886
    [Abstract] [Full Text] [Related]

  • 23. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL, Rauth AM, Bendayan R, Wu XY.
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [Abstract] [Full Text] [Related]

  • 24. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
    Menna P, Salvatorelli E, Minotti G.
    Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
    [Abstract] [Full Text] [Related]

  • 25. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X, Zhou Z, Kang YJ.
    Cancer Res; 2001 Apr 15; 61(8):3382-7. PubMed ID: 11309296
    [Abstract] [Full Text] [Related]

  • 26. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study.
    Kogan NM, Schlesinger M, Peters M, Marincheva G, Beeri R, Mechoulam R.
    J Pharmacol Exp Ther; 2007 Aug 15; 322(2):646-53. PubMed ID: 17478614
    [Abstract] [Full Text] [Related]

  • 27. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
    Khan M, Shobha JC, Mohan IK, Naidu MU, Sundaram C, Singh S, Kuppusamy P, Kutala VK.
    Phytother Res; 2005 Dec 15; 19(12):1030-7. PubMed ID: 16372368
    [Abstract] [Full Text] [Related]

  • 28. Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.
    Hirano S, Wakazono K, Agata N, Iguchi H, Tone H.
    Drugs Exp Clin Res; 1994 Dec 15; 20(4):153-60. PubMed ID: 7813387
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels.
    Wang GW, Kang YJ.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):938-44. PubMed ID: 10027829
    [Abstract] [Full Text] [Related]

  • 30. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R, Boroujerdi M.
    Cancer Chemother Pharmacol; 2005 Nov 15; 56(5):497-509. PubMed ID: 15937726
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice.
    Bruynzeel AM, Vormer-Bonne S, Bast A, Niessen HW, van der Vijgh WJ.
    Cancer Chemother Pharmacol; 2007 Sep 15; 60(4):509-14. PubMed ID: 17177067
    [Abstract] [Full Text] [Related]

  • 32. S-allylcysteine ameliorates doxorubicin toxicity in the heart and liver in mice.
    Mostafa MG, Mima T, Ohnishi ST, Mori K.
    Planta Med; 2000 Mar 15; 66(2):148-51. PubMed ID: 10763589
    [Abstract] [Full Text] [Related]

  • 33. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY, Najjar TA, Alashari M.
    J Biochem Mol Toxicol; 2004 Mar 15; 18(2):78-86. PubMed ID: 15122649
    [Abstract] [Full Text] [Related]

  • 34. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE, Asker ME, Ali SI, el-Fattah TM.
    J Pharm Pharmacol; 2004 Jun 15; 56(6):757-68. PubMed ID: 15231041
    [Abstract] [Full Text] [Related]

  • 35. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S, Tani M, Okamura J, Ogawa M, Ohashi Y, Monden M, Hayashi S, Inoue J, Kawarada Y, Kusano M, Kubo Y, Kuroda C, Sakata Y, Shimamura Y, Jinno K, Takahashi A, Takayasu K, Tamura K, Nagasue N, Nakanishi Y, Makino M, Masuzawa M, Yumoto Y, Mori T, Oda T.
    Semin Oncol; 1997 Apr 15; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [Abstract] [Full Text] [Related]

  • 36. The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice.
    Abou El Hassan MA, Kedde MA, Zwiers UT, Bast A, van der Vijgh WJ.
    Cancer Chemother Pharmacol; 2003 Apr 15; 51(4):306-10. PubMed ID: 12721758
    [Abstract] [Full Text] [Related]

  • 37. Time-course of lipid peroxidation in different organs of mice treated with Echis pyramidum snake venom.
    Al Asmari A, Al Moutaery K, Manthari RA, Khan HA.
    J Biochem Mol Toxicol; 2006 Apr 15; 20(2):93-5. PubMed ID: 16615057
    [Abstract] [Full Text] [Related]

  • 38. Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity.
    Bai P, Mabley JG, Liaudet L, Virág L, Szabó C, Pacher P.
    Oncol Rep; 2004 Feb 15; 11(2):505-8. PubMed ID: 14719091
    [Abstract] [Full Text] [Related]

  • 39. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR, Della Torre P, Mazué G, Sullivan TM, Robbins TL, Hagerman LM, Podestà A, Pinciroli G.
    Cancer Res; 1996 Sep 15; 56(18):4200-4. PubMed ID: 8797592
    [Abstract] [Full Text] [Related]

  • 40. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
    Crescimanno M, Flandina C, Rausa L, Sanguedolce R, D'Alessandro N.
    Chemioterapia; 1988 Feb 15; 7(1):53-9. PubMed ID: 3163942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.